On-demand proton pump inhibitor therapy in patients with gastro-oesophageal reflux disease
- 1 December 2002
- journal article
- review article
- Published by Elsevier in Digestive and Liver Disease
- Vol. 34 (12) , 870-877
- https://doi.org/10.1016/s1590-8658(02)80259-6
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a Health Maintenance OrganizationAmerican Journal of Gastroenterology, 2000
- On demand therapy of reflux oesophagitis - a prospective study of symptoms, patient satisfaction and quality of lifeAlimentary Pharmacology & Therapeutics, 1999
- Updated Guidelines for The Diagnosis and Treatment of Gastroesophageal Reflux DiseaseAmerican Journal of Gastroenterology, 1999
- An evidence-based appraisal of reflux disease management --- the Genval Workshop ReportGut, 1999
- Opposing time trends of peptic ulcer and reflux diseaseGut, 1998
- On‐demand treatment of gastro‐oesophageal reflux symptoms: a comparison of ranitidine 75 mg with cimetidine 200 mg or placeboAlimentary Pharmacology & Therapeutics, 1998
- The Impact of Gastroesophageal Reflux Disease on Health-related Quality of Life 11Supported by research funding from Astra/Merck, Wayne, Pennsylvania.The American Journal of Medicine, 1998
- Meta-Analysis of the Effect of Placebo on the Outcome of Medically Treated Reflux EsophagitisScandinavian Journal of Gastroenterology, 1995
- Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junctionGastroenterology, 1993
- Three year follow up of patients with gastrooesophageal reflux disease.Gut, 1992